Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Jost, V; Fluhr, H; Helmer, H; Göbl, C.
Commentary: Antenatal corticosteroid prophylaxis in late preterms- short- and long-term effects and many open questions.
BMC Pregnancy Childbirth. 2025; 25(1):197
Doi: 10.1186/s12884-025-07316-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Jost Viktoria
- Co-authors Med Uni Graz
- Fluhr Herbert
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Antenatal corticosteroids are a well-established treatment for fetal lung maturation before 34 + 0 weeks of gestation. The administration of dexamethasone and betamethasone in late preterm - between 34 + 0 and 36 + 6 weeks of gestation - is still highly debated and subject of recent research. This topic was recently addressed by a retrospective observational cohort study aiming to investigate the benefits, short- and long-term risks of the application of antenatal corticosteroids in the late preterm phase. This commentary will discuss the main findings of the article and its implications for further research.
- Find related publications in this database (using NLM MeSH Indexing)
- Humans - administration & dosage
- Pregnancy - administration & dosage
- Female - administration & dosage
- Betamethasone - administration & dosage, therapeutic use
- Dexamethasone - therapeutic use, administration & dosage
- Infant, Newborn - administration & dosage
- Prenatal Care - methods
- Glucocorticoids - administration & dosage, therapeutic use
- Infant, Premature - administration & dosage
- Gestational Age - administration & dosage
- Premature Birth - prevention & control
- Respiratory Distress Syndrome, Newborn - prevention & control
- Retrospective Studies - administration & dosage
- Adrenal Cortex Hormones - administration & dosage, therapeutic use
- Fetal Organ Maturity - drug effects